Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150,858,761
-
Total 13F shares
-
45,418,262
-
Share change
-
+216,512
-
Total reported value
-
$1,079,557,657
-
Price per share
-
$23.77
-
Number of holders
-
104
-
Value change
-
+$3,680,968
-
Number of buys
-
47
-
Number of sells
-
42
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q4 2021
As of 31 Dec 2021,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,418,262 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., EcoR1 Capital, LLC, FEDERATED HERMES, INC., Cormorant Asset Management, LP, VANGUARD GROUP INC, Avidity Partners Management LP, and STATE STREET CORP.
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.